$LDOS

Is Leidos Holdings (LDOS) Undervalued As Raised Guidance And New Contracts Lift Outlook?

Leidos Holdings (NYSE:LDOS) reported Q2 2026 results with higher sales but lower net income, raised its full-year revenue outlook, and cited defense and intelligence contract wins. The article notes LDOS shares rebounded after the update, and presents a “fair value” of $165.27 versus a $137.57 close.

Original reporting
Published Aug 10, 2026, 12:31 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Leidos Holdings (LDOS) Undervalued As Raised Guidance And New Contracts Lift Outlook? — source image
Decision brief

The 30-second read

$LDOSBullishMed
01

Why it matters

For traders, the key is whether the raised revenue guidance and contract momentum can offset the reported decline in net income and sustain margin improvement.

02

Market read

LDOS is presented as a guidance-and-contract momentum story after a sharp share-price rebound, with valuation gap and margin assumptions driving the bullish narrative.

03

What to watch

The article warns that shifts in US federal spending priorities or persistent healthcare contract pressures could derail the guidance-driven thesis.

Relevance 5/10Novelty 4/10Timing: post-Q2 results, guidance update and contract-win narrative dated Aug 10, 2026

Background

Simply Wall St frames LDOS as undervalued after a rebound, citing Q2 results, raised full-year revenue outlook, and recent defense and intelligence contract wins.

Company-level read

Ticker impact

$LDOSBullishMedium confidence
Context

Leidos (LDOS) reported Q2 2026 results, raised full-year revenue guidance, and cited defense and intelligence contract wins.

Expected impact

Near-term bias to upside as investors digest guidance and contract momentum; follow-through depends on margin trajectory given Q2 net income weakness.

Evidence & confidence

The article’s actionable catalyst is the raised full-year revenue outlook and highlighted contract wins, while it also flags lower net income, implying investors will scrutinize margins and execution.

Market effects

Reinforces demand themes in defense and intelligence services tied to digital modernization, AI solutions, and autonomous systems.

Primarily US federal spending and defense procurement sensitivity.

Limited, as the article centers on US government and domestic defense/intelligence contracting.

Counterpoint

The valuation-undervaluation framing may be overstated if margin pressure persists, especially since Q2 net income fell despite higher sales.

Key entities

  • Leidos Holdings

    US defense and intelligence services provider discussed as having raised full-year revenue outlook and won new contracts.

Related articles

$LDOSHighAI 9/10

Are Wall Street Analysts Bullish on Leidos Holdings Stock?

Leidos Holdings (LDOS), a defense and tech services company, has underperformed the market and sector ETFs due to contract issues and government budget constraints. Despite this, LDOS reported strong Q2 earnings, beating estimates with $3.26 adjusted EPS and $4.6B revenue. Analysts have a 'Moderate Buy' consensus, with a mean price target of $160.12, implying 11.6% upside. Wells Fargo raised its target to $165, suggesting 15% potential gain.

$BAMed

Pentagon seeks weapons production boost

Pentagon deputy secretary Steve Feinberg asked major U.S. defense firms to accelerate production and deliveries of weapons and sensors, citing concerns about shortages and gaps tied to the Iran conflict. In an Aug. 5 letter seen by Bloomberg, he targeted programs including wide-area surveillance, air-defense sensors and interceptors, and missile-tracking systems, asking for plans by late August.

$LDOSMedAI 8/10

Leidos Holdings, Inc. Q2 2026 Earnings Call Summary

Leidos Holdings reported record Q2 2026 revenue of $4.6 billion and a 1.1 book-to-bill ratio, with Defense at a 2.2 book-to-bill. Full-year revenue guidance was raised by $100 million at the midpoint. Health faces VA incentive payment suspension, while Homeland grew 32%. Capex guidance was cut to about $250 million and share repurchases were authorized.

$LDOSMedAI 8/10

12 Companies Win Spots on DHS $1.5B Counter-Drone IDIQ

DHS awarded 14 positions on a $1.5B counter-drone IDIQ, split into Track 1 (ceiling $1.01B) for hardware and services and Track 2 (ceiling $489M) for comprehensive services, per USAspending. Leidos and BAE Systems won both tracks; others received single-track spots. Ordering runs Aug. 1, 2026 to July 31, 2031, with a $250M minimum guarantee at award.

$LDOSMedAI 8/10

Leidos Secures $64.8M Contract to Continue Modernizing Naval Intelligence Communications Systems

Leidos said it won a contract with the Office of Naval Intelligence worth up to $64.8 million, including a base year and four option years, to continue modernizing naval intelligence communications infrastructure. The work builds on Leidos efforts since 2021 and supports the Hopper Global Communications Center, aimed at secure information sharing and technology integration, according to the company.